2026³â08¿ù30ÀÏsun
·Î±×ÀÎ | ȸ¿ø°¡ÀÔ
OFF
Æ®À§ÅÍ·Î º¸³»±â ½ÎÀÌ¿ùµå °ø°¨
±â»ç±ÛÈ®´ë ±â»ç±ÛÃà¼Ò ±â»ç½ºÅ©·¦ À̸ÞÀϹ®ÀÇ ÇÁ¸°Æ®Çϱâ
6ÀÏ »ï¼ººÐÀÚÀÇÇÐ ±¹Á¦½ÉÆ÷Áö¾ö ¿­·Á
[ 2004³â 11¿ù 02ÀÏ 02½Ã 26ºÐ ]
»ï¼º»ý¸í°úÇבּ¸¼Ò(¼ÒÀå ¾ö´ë¿ë)¿Í »ï¼º¼­¿ïº´¿ø, ¼º±Õ°üÀÇ´ë´Â °øµ¿À¸·Î ¿À´Â 6ÀÏ ¿ÀÀü 9½ÃºÎÅÍ »ï¼º¼­¿ïº´¿ø ´ë°­´ç¿¡¼­ 'Á¦10ȸ »ï¼ººÐÀÚÀÇÇб¹Á¦½ÉÆ÷Áö¾ö'À» °³ÃÖÇÑ´Ù.

2ÀÏ ¿¬±¸¼Ò¿¡ µû¸£¸é 'Àΰ£Áúȯ¿¡ ´ëÇÑ À¯ÀüüÀû Á¢±Ù(Genomic Approach to Human Disease)'À» ÁÖÁ¦·Î ¿­¸®´Â À̹ø ½ÉÆ÷Áö¾ö¿¡¼­´Â ¼¼°èÀû ¼®ÇеéÀÌ ´ë°Å ÃÊûµÅ °³°³ÀÎÀÇ À¯ÀüÀû Â÷À̰¡ Áúº´ÀÇ ¿øÀÎ ¹× ¹ß´Þ°úÁ¤¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Áúº´ Ä¡·á Ãø¸é¿¡¼­ ³íÀÇÇÏ´Â ½Ã°£ÀÌ ¸¶·ÃµÈ´Ù.

¿¬Á¦·Î´Â ¡ã Population Genetic Approaches to Studying The Genetics of Complex Diseases(½ÃÄ«°í´ëÇÐ Àΰ£À¯ÀüüÇкΠJonathan Pritchard ¹Ú»ç) ¡ã Mapping of Susceptibility(µµÄì´ë Katsushi Tokunaga ¹Ú»ç) ¡ãSNPs That Are Not SNPs,MSVs, PSVs and Other Challenges to The Study of Human DNA Variation(¿µ±¹ ·¹½ºÅÍ ´ëÇÐ Anthony Brookes ¹Ú»ç)¡ãLinkage and Linkage Disequilibrium Mapping of Stuttering(½ÃÄ«°í´ë Àΰ£À¯ÀüüÇкΠNancy Cox ¹Ú»ç) µîÀÌ ¹ßÇ¥µÈ´Ù.

¶Ç ¡ãintegration of Tissue Microdissection into Genomics and Proteomics:A New Approach to Study Diseases(¹Ì±¹ ±¹¸³º¸°Ç¿ø(NIH) Zhengping Zhuang ¹Ú»ç)¡ãProteomics Approach to Cancer Research(¿¬¼¼ÀÇ´ë ±èÈ£±Ù ±³¼ö)¡ã The Integrated Understanding of Genetic/Environmental Factors In The Predictive Pharmacogenetics(ÀÎÁ¦´ë ½ÅÀç±¹ ±³¼ö)¡ãThe Genetics of Variable Drug Response(¿µ±¹ ·±´øÀ¯´Ï¹ö½ÃƼ Ä®¸®Áö´ë David Goldstein¹Ú»ç) µîÀÇ °­¿¬µµ À̾îÁø´Ù.
±èÇöÁ¤±âÀÚ hjkim@dailymedi.com
À̱âÀÚÀÇ ´Ù¸¥´º½ºº¸±â
¹«ÅëÀåÀÔ±Ý Á¤º¸ÀÔ·Â ÀÔ±ÝÀÚ¸í ÀԱݿ¹Á¤ÀÏÀÚ
(ÀÔ±ÝÇÏ½Ç ÀÔ±ÝÀÚ¸í + ÀԱݿ¹Á¤ÀÏÀÚ¸¦ ÀÔ·ÂÇϼ¼¿ä)
[°ü·Ã´º½º]
- °ü·Ã´º½º°¡ ¾ø½À´Ï´Ù.
Æ®À§ÅÍ·Î º¸³»±â ½ÎÀÌ¿ùµå °ø°¨
±â»ç±ÛÈ®´ë ±â»ç±ÛÃà¼Ò ±â»ç½ºÅ©·¦ À̸ÞÀϹ®ÀÇ ÇÁ¸°Æ®Çϱâ
¸íÁöº´¿ø, ͺ À̰ÇÈñ ȸÀå ÁÖÄ¡ÀÇ À̰­¿ì ±³¼ö(»ï¼º¼­¿ïº´¿ø ÀçȰÀÇÇаú) ¿µÀÔ
´ëÀü¼º¸ðº´¿ø ±èµ¿±â¡¤À̵¿Ã¢ ±³¼ö, ´ëÇÑÀ̺ñÀÎÈİúÇÐȸ ÃÖ¿ì¼ö ±¸¿¬»ó¡¤ÃÖ¿ì¼ö Æ÷½ºÅÍ»ó
Á¶Àç¿ì ±³¼ö(°í´ë±¸·Îº´¿ø Á¤Çü¿Ü°ú), ´ëÇѰñÀýÇÐȸ ÃÖ´Ù³í¹®»ó
´ëÇÑÀÇ»çÇùȸ ºÎȸÀå ¹éÇö¿í¡¤Àǹ«ÀÌ»ç ¿Àµ¿È£¡¤Á¤º¸Åë½ÅÀÌ»ç À¯¼Ò¿µèâ
Çѱ¹Á¦¾à¹ÙÀÌ¿ÀÇùȸ ÀǾàǰ±¤°í½ÉÀÇÀ§¿øÈ¸ À§¿øÀå ±è¼ºÁø¡¤ºÎÀ§¿øÀå ÀÌÁØÈñ¡¤ÀåÃá°ï èâ
¹è±â¼ö ±³¼ö(¾ÆÁִ뺴¿ø ¼Ò¾ÆÃ»¼Ò³â°ú), Á¦100ȸ ¾î¸°À̳¯ ¿ÁÁ¶±ÙÁ¤ÈÆÀå
À̺´ÈÆ¡¤½ÉÀç¾Ó ±³¼öÆÀ(±æº´¿ø Á¤Çü¿Ü°ú), ´ëÇѰñÀýÇÐȸ ¿ÃÇØ ¿ì¼ö ±¸¿¬»ó
³²°¡Àº ±³¼ö(°í´ë±¸·Îº´¿ø °¡Á¤ÀÇÇаú), Çѱ¹¿©ÀÚÀÇ»çȸ Á¦4ȸ ÀþÀºÀÇÇÐÀÚ Çмú»ó
±¹¸³Áß¾ÓÀÇ·á¿ø Áß¾ÓÀÀ±ÞÀÇ·á¼¾ÅÍÀå ±è¼ºÁß(Á¶¼±´ëº´¿ø ÀÀ±ÞÀÇÇаú ±³¼ö)
ÃÖÁ¤¿õ ¿µ°æÀÇ·áÀç´Ü ÀüÁÖº´¿ø ÀÌ»çÀå, ¾Æµ¿º¸È£»ç¾÷ ±â±Ý 4000¸¸¿ø
±è¿µÁÖ ±³¼ö(ÀÌ´ë¸ñµ¿º´¿ø »êºÎÀΰú), Á¦13ȸ Çѵ¶¿©ÀÇ»çÇмú´ë»ó
¹ÚÂùÈì ±³¼ö(ÇѸ²´ëÃáõ¼º½Éº´¿ø À̺ñÀÎÈİú), ´ëÇÑÀ̺ñÀÎÈİúÇÐȸ Çмú»ó
Á¶¼öÁø ±³¼ö(ÇѸ²´ëµ¿Åº¼º½Éº´¿ø ½Å°æ°ú), Á¦26ȸ JWÁß¿ÜÇмú´ë»ó
¼­Á¤°Ç ¿¬¼¼¼­³»°ú ¿øÀå ÀåÀλó